Insilico now has a pipeline of more than 40 AI-developed drugs it is developing for conditions such as cancer, bowel and kidney disease.
With AI taking the top spot for 2026 government CIO priorities, what are the next-level questions that leaders must focus on ...
HONG KONG SAR - EQS Newswire - 30 December 2025 - Uni-Bio Science Group Limited ("Uni-Bio Science Group", "Uni-Bio" or "the Group") is pleased to announce the official signing of a tripartite ...
Zacks Investment Research on MSN
Three genomics stocks worth tracking this year
An updated edition of the Nov. 18, 2025, article. Genomics is a broad and detailed study of genomes (an organism’s complete set of deoxyribonucleic acid or DNA). Recent scientific advances in this ...
Data masking and anonymization solutions are used by organizations to safeguard sensitive data by removing personal ...
In its inaugural year, BoothHacks brought together 132 student builders, 37 new AI-powered products, and 10 judges for a high ...
NVIDIA is ushering in a new era of AI-defined driving, bringing its advanced NVIDIA DRIVE AV software to U.S. roads by the ...
Vividion Therapeutics, Inc. (Vividion), a clinical-stage biopharmaceutical company, and a wholly owned and independently operated subsidiary of Bayer AG, today announced the publication of a ...
A personal reflection on the promise and limits of CAR T therapy—its breakthroughs, failures, scientific bottlenecks, and what must change to truly save more lives.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback